Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): What's the difference?

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 12, 2010, Pages

  Burgers, Janneke A ^a   Fong, Sharon Lie ^a   Louwers, Yvonne V ^a   Valkenburg, Olivier ^a   De Jong, Frank H ^a   Fauser, Bart C J M ^b   Laven, Joop S E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADOLESCENT; ADULT; AMENORRHEA; ANDROGEN BLOOD LEVEL; ANOVULATION; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OLIGOOVULATION; OVARY DISEASE; OVARY FOLLICLE; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TERTIARY HEALTH CARE;

EID: 78650036514     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2717     Document Type: Article

References (17)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group2004 Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS).Hum Reprod 19:41-47
3. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC 2006 PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113:1210-1217
4. Barber TM, Wass JA, McCarthy MI, Franks S 2007 Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 66:513-517
5. Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA 2005 Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90:2545-2549 (Pubitemid 40686289)
6. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2008 Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89:505-522
7. van Santbrink EJ, Fauser BC 2006 Ovulation induction in normogonadotropic anovulation (PCOS). Best Pract Res Clin Endocrinol Metab 20:261-270
8. Wathen NC, Perry L, Lilford RJ, Chard T 1984 Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) 288:7-9 (Pubitemid 14115324)
9. Israel R, Mishell Jr DR, Stone SC, Thorneycroft IH, Moyer DL 1972 Single luteal phase serum progesterone assay as an indicator of ovulation. Am J Obstet Gynecol 112:1043-1046
10. Valkenburg O, Uitterlinden AG, Piersma D, Hofman A, Themmen AP, de Jong FH, Fauser BC, Laven JS 2009 Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod 24:2014-2022
11. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC 1998 Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83:2361-2365
12. Imani B, Eijkemans MJ, Faessen GH, Bouchard P, Giudice LC, Fauser BC 2002 Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril 77:83-90 (Pubitemid 34093897)
13. Mulders AG, Eijkemans MJ, Imani B, Fauser BC 2003 Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online 7:170-178 (Pubitemid 37121060)
14. Laven JS, Imani B, Eijkemans MJ, Fauser BC 2002 New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57:755-767 (Pubitemid 35379455)
15. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ 2009 Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 92:1966-1982
16. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC 1999 Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84:1617-1622
17. Franks S, Stark J, Hardy K 2008 Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14:367-378 (Pubitemid 351858976)